HCA Healthcare Inc Stock (ISIN: US4041211033) Drops 2.8% to $509 Amid Institutional Buying and Strong FY2026 Guidance

robot
Abstract generation in progress

HCA Healthcare Inc. stock fell 2.8% to $509.87 on March 17, 2026, despite strong Q4 earnings, beating EPS estimates, and optimistic FY2026 guidance. Institutional investors, including Achmea and Danske Bank, increased their holdings, indicating confidence in the company’s operational strength. Analysts maintain a “Moderate Buy” consensus with an average price target of $537.73, suggesting potential upside, driven by HCA’s admissions growth and margin expansion.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin